Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Century Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 72 | 100 | +28 |
| Shares | 140.2M | 158.0M | +17.9M (+12.7%) |
| Value | $315.6M | $387.0M | +$71.4M (+22.6%) |
New holders (38)
Institutions that held Century Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (10)
Institutions that held Century Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Syncona Portfolio Ltd | 1,213,056 | $2.74M |
| Acadian Asset Management LLC | 278,075 | $627.0K |
| Superstring Capital Management LP | 119,308 | $269.6K |
| Brevan Howard Capital Management LP | 96,641 | $218.4K |
| Cannon Global Investment Management, LLC | 49,000 | $110.7K |
| Omers Administration Corp | 47,800 | $108.0K |
| XTX Topco Ltd | 22,518 | $50.9K |
| Simplex Trading, LLC | 9,028 | $20.4K |
| Farther Finance Advisors, LLC | 2,500 | $5.47K |
| Advisory Services Network, LLC | 407 | $920 |